10-K Decoder · All companies

Dianthus Therapeutics, Inc.

DNTH · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Mar 2026

Open the dashboardInfographicSummary

FY2025 key figures

$FY2025FY2024Change
Revenue$2.04M$6.24M−67.3%
Operating income−$178M−$102M−74.7%
Net income−$162M−$85.0M−91.1%

Questions

What was Dianthus's revenue in FY2025?
$2.04M in FY2025 (Fiscal year ended Dec 31, 2025), −67.3% vs $6.24M a year earlier, per its 10-K filed Mar 2026.
Was Dianthus profitable in FY2025?
No: net income was −$162M and operating income −$178M in FY2025.